Clinical Trial Update: Phase 1 Pharmacokinetic Study of Oral Ixazomib Plus Lenalidomide and Dexamethasone in Adult Asian Participants With Relapsed and/or Refractory Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of oral ixazomib with lenalidomide and dexamethasone in adult Asian patients with relapsed/refractory multiple myeloma has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• ixazomib (ixazomib)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED | Results posted: 2018-11-08